Publication

Pleiotropic genes for metabolic syndrome and inflammation

Downloadable Content

Persistent URL
Last modified
  • 05/20/2025
Type of Material
Authors
    Aldi T. Kraja, Washington UniversityDaniel I. Chasman, Brigham & Women's HospitalKari E. North, University of North CarolinaAlexander P. Reiner, University of WashingtonLisa R. Yanek, Johns Hopkins UniversityTuomas O. Kilpelainen, University of CopenhagenJennifer A. Smith, University of MichiganAbbas Dehghan, Erasmus Medical CenterJosee Dupuis, National Heart, Lung, and Blood InstituteAndrew D. Johnson, National Heart, Lung, and Blood InstituteMary F. Feitosa, Washington UniversityFasil Tekola-Ayele, Boston UniversityAudrey Y. Chu, Brigham & Women's HospitalIlja M. Nolte, University of GroningenZari Dastani, McGill UniversityAndrew Morris, University of OxfordSarah A. Pendergrass, Pennsylvania State UniversityYan Sun, Emory UniversityMarylyn D. Ritchie, Pennsylvania State UniversityAhmad Vaez, University of Groningen
Language
  • English
Date
  • 2014-08-01
Publisher
  • Elsevier: 12 months
Publication Version
Copyright Statement
  • © 2014 Elsevier Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1096-7192
Volume
  • 112
Issue
  • 4
Start Page
  • 317
End Page
  • 338
Grant/Funding Information
  • Complete funding list available in full text.
Supplemental Material (URL)
Abstract
  • Metabolic syndrome (MetS) has become a health and financial burden worldwide. The MetS definition captures clustering of risk factors that predict higher risk for diabetes mellitus and cardiovascular disease. Our study hypothesis is that additional to genes influencing individual MetS risk factors, genetic variants exist that influence MetS and inflammatory markers forming a predisposing MetS genetic network. To test this hypothesis a staged approach was undertaken. (a) We analyzed 17 metabolic and inflammatory traits in more than 85,500 participants from 14 large epidemiological studies within the Cross Consortia Pleiotropy Group. Individuals classified with MetS (NCEP definition), versus those without, showed on average significantly different levels for most inflammatory markers studied. (b) Paired average correlations between 8 metabolic traits and 9 inflammatory markers from the same studies as above, estimated with two methods, and factor analyses on large simulated data, helped in identifying 8 combinations of traits for follow-up in meta-analyses, out of 130,305 possible combinations between metabolic traits and inflammatory markers studied. (c) We performed correlated meta-analyses for 8 metabolic traits and 6 inflammatory markers by using existing GWAS published genetic summary results, with about 2.5 million SNPs from twelve predominantly largest GWAS consortia. These analyses yielded 130 unique SNPs/genes with pleiotropic associations (a SNP/gene associating at least one metabolic trait and one inflammatory marker). Of them twenty-five variants (seven loci newly reported) are proposed as MetS candidates. They map to genes MACF1, KIAA0754, GCKR, GRB14, COBLL1, LOC646736-IRS1, SLC39A8, NELFE, SKIV2L, STK19, TFAP2B, BAZ1B, BCL7B, TBL2, MLXIPL, LPL, TRIB1, ATXN2, HECTD4, PTPN11, ZNF664, PDXDC1, FTO, MC4R and TOMM40. Based on large data evidence, we conclude that inflammation is a feature of MetS and several gene variants show pleiotropic genetic associations across phenotypes and might explain a part of MetS correlated genetic architecture. These findings warrant further functional investigation.
Author Notes
  • Aldi T. Kraja, DSc, PhD, Division of Statistical Genomics, Department of Genetics and Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63108, phone: 314-362-2498, aldi@wustl.edu
Keywords
Research Categories
  • Biology, Genetics
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items